Immatics' lead asset, IMA203, shows promising early data with a 57% ORR in heavily pretreated patients, but toxicity concerns ...

Lender fees have gone back into effect starting this week for Fiscal Year 2025. Over the coming weeks, the SBA will announce ...

Exceeds first quarter revenue and profit guidanceReiterates full year guidance and remains on track to generate approximately $625 million to $650 million of adjusted free cash flow for the yearExpect ...